BTAIVSVBIO• 3 Months (Normalized)
BTAI vs VBIO (BioXcel Therapeutics Inc. vs Valion Bio Inc.)
Showing Closing Date Range from Jun, 16 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-96.24%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
VBIO Performance $2.1
-85%
Valion Bio Inc.
Normalized Baseline0.00%
Alpha Spread Margin VBIO LEADS
-11.24%
VBIO outperforming by 11.24%
BTAIVBIO
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI VBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | BTAI Price | BTAI Gain (%) | VBIO Price | VBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $0.05 | -96.24% | $2.10 | -85.00% | -11.24% |
| Sep 11, 2026 | $0.05 | -95.75% | $2.26 | -83.86% | -11.89% |
| Sep 10, 2026 | $0.05 | -95.83% | $2.20 | -84.29% | -11.54% |
| Sep 09, 2026 | $0.05 | -96.08% | $2.40 | -82.86% | -13.22% |
| Sep 08, 2026 | $0.04 | -96.42% | $2.50 | -82.14% | -14.28% |
| Sep 04, 2026 | $0.07 | -93.84% | $2.77 | -80.21% | -13.63% |
| Sep 03, 2026 | $0.12 | -90.17% | $2.80 | -80.00% | -10.17% |
| Sep 02, 2026 | $0.11 | -91.08% | $3.12 | -77.71% | -13.37% |
| Sep 01, 2026 | $0.14 | -88.58% | $3.07 | -78.07% | -10.51% |
| Aug 31, 2026 | $0.16 | -86.42% | $3.57 | -74.50% | -11.92% |
| Aug 28, 2026 | $0.18 | -84.92% | $3.03 | -78.39% | -6.53% |
| Aug 27, 2026 | $0.72 | -40.08% | $3.08 | -78.04% | +37.96% |
| Aug 26, 2026 | $0.78 | -35.00% | $3.90 | -72.14% | +37.14% |
| Aug 25, 2026 | $0.74 | -38.17% | $3.98 | -71.61% | +33.44% |
| Aug 24, 2026 | $0.76 | -36.58% | $4.15 | -70.36% | +33.78% |
Page 1 of 5